GSK Roundup: Whence The $3 Billion Figure As A China Fine
This article was originally published in PharmAsia News
Executive Summary
A PharmaAsia News review of media reports finds the idea of China fining GlaxoSmithKline $3 billion for its alleged corruption was generated in offhand remarks at a press conference in July and not a figure ever put forth by Chinese authorities as under consideration.